about
Endoscopic and histologic characteristics of serrated lesions[Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data]Effective use of argon plasma coagulation in the treatment of severe radiation proctitis.Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.[Specific carbohydrate malabsorption]Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.Dietary patterns, digestive symptoms, and health-related quality of life in women reporting minor digestive symptoms.Dose-related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate.Tolerance and breath hydrogen excretion following ingestion of maltitol incorporated at two levels into milk chocolate consumed by healthy young adults with and without fasting.Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo.Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.Tolerance to low-digestible carbohydrates: symptomatology and methods.Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly.The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study.Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.Chronic diarrhoea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth.Laparoscopic total colectomy: Does the indication influence the outcome?Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE).Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.Enrichment of Circulating and Mucosal Cytotoxic CD8+ T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn's DiseaseTacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma.Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.Colon cancer in inflammatory bowel disease: recent trends, questions and answers.Factors associated with impaired quality of life in French patients with chronic idiopathic constipation: a cross-sectional study.Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease.Abdominal necrotic abscess from colonic fistula treated endoscopically.CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cells.Can diarrhea induced by lactulose be reduced by prolonged ingestion of lactulose?Transcutaneous posterior tibial nerve stimulation for fecal incontinence in inflammatory bowel disease patients: a therapeutic option?Gastric clearance of alpha-1-antitrypsin under cimetidine perfusion. New test to detect protein-losing gastropathy?Butyrate strongly inhibits in vitro stimulated release of cytokines in blood.Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation.Is scintigraphic double-track appearance a sign of severe acute episodes of ulcerative colitis?[Chronic active ulcerative colitis. Efficacy of intravenous followed by oral cyclosporine combined with azathioprine].
P50
Q27021798-2E45FF26-1503-44CC-8915-7B0B9A8C5E83Q30596104-C749ECA4-8455-4691-BB46-D9352749C8B8Q32048109-1B03B908-1EEC-4C9E-B7F1-4E95E2735BF2Q33268368-1EC1F223-C85B-41F2-947C-06453B4194A0Q33423460-7CA5D7FF-A3E3-4897-9EFC-C6CF1F4C051FQ33431282-6E33C53A-A454-43DC-BEFC-1491C4C2FB82Q33469918-DC24E687-CF2D-4AFE-9A65-6D21E13BEC67Q33485702-E7E16AE6-A842-44F7-A236-9FC0EB3EA07EQ33487331-6043FBEC-9642-449F-846E-331740F8E451Q33730054-1D0930FF-5156-4234-8613-DABE162DB2DDQ33815262-DDF76218-DD16-4ABC-A277-40844DD0E58DQ34230591-4FCE3BA6-21A3-4E2A-BE6E-E7C47249DAA8Q34297676-E22BE4AE-F0D6-4B80-AF22-0AE20C60820EQ34374509-BF11D661-3FAB-4AB9-8C09-27F7A9D8DD69Q34489016-C2CB8519-70CF-4853-A96F-0D01C517E42EQ34648896-76F7D55D-E612-4512-B515-D9887003E51EQ34756603-017368D1-F22D-48D0-ACC9-B49BB9EDC1B4Q35618819-BBC11E96-5F93-4BEC-B142-E42A71691CC8Q36192570-DDBA3DCE-4107-4A0C-A5E3-A668ED9141B2Q36315564-D91C6D18-4B15-46CE-B304-72A283BD8967Q36735647-D44AB38B-3DB2-4110-AA40-28C4F252F7D6Q37118466-D1C924C1-D274-4F2A-BBB0-F0CF0BFA3453Q38229318-9BD72AC2-D4E5-49EA-BF8F-0827D59CB129Q38285641-C2C465B4-2158-40FE-96E2-676BED0D69EFQ39077823-13D673C7-2C20-4CAD-B502-8B55D3D26C11Q39301760-9DAC882D-0F9C-4D6A-B5B2-A30587E0B0EDQ39640911-F306FDD4-D378-4E50-8313-BE698425355FQ39904958-B884CF11-5CDB-4B67-A282-9E5FCE021337Q40008374-416917A0-E2C9-4602-90E9-4E87B68E5D79Q40472089-FC88A38F-FD31-45AE-9F87-D61030B52FF9Q41070109-E06D4F18-21B8-4B1F-AE0B-7221D60629EFQ41387728-DFEF1AEB-F25F-42FC-929E-3180051FA529Q43258042-4F2459D4-7A2C-44A3-A45C-C02A03D46634Q43328365-27233BDF-4B7C-439F-8068-7F8AFFFDC12FQ43365740-8273D3B2-7650-472B-ACA0-FC0808FE31D5Q43415257-4326CC02-957F-497B-809A-93ECF2D00FBBQ43980803-B3230B57-7442-4847-AA40-4A1DD2D573F0Q44841392-2E9D84AA-C28C-44B2-B845-781B1416CDFBQ44849715-505B275C-AB2F-4F42-89D1-71657E827280Q44958948-2C45AA60-2873-4AEB-B6FE-59A1E660C813
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Bernard Flourié
@en
Flourié B
@ast
Flourié B
@es
Flourié B
@nl
type
label
Bernard Flourié
@en
Flourié B
@ast
Flourié B
@es
Flourié B
@nl
altLabel
Flourié B
@en
prefLabel
Bernard Flourié
@en
Flourié B
@ast
Flourié B
@es
Flourié B
@nl
P31
P496
0000-0002-3300-0299